FCAKX
Price
$43.47
Change
-$0.62 (-1.41%)
Updated
Jun 13 closing price
Net Assets
6.55B
RGAGX
Price
$78.43
Change
-$0.94 (-1.18%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

FCAKX vs RGAGX

Header iconFCAKX vs RGAGX Comparison
Open Charts FCAKX vs RGAGXBanner chart's image
Fidelity Capital Appreciation K
Price$43.47
Change-$0.62 (-1.41%)
VolumeN/A
Net Assets6.55B
American Funds Growth Fund of Amer R6
Price$78.43
Change-$0.94 (-1.18%)
VolumeN/A
Net Assets306.22B
FCAKX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FCAKX vs. RGAGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCAKX is a Buy and RGAGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 306B vs. FCAKX (6.55B). RGAGX pays higher dividends than FCAKX: RGAGX (0.65) vs FCAKX (0.22). FCAKX was incepted earlier than RGAGX: FCAKX (17 years) vs RGAGX (16 years). FCAKX (0.49) is less costly to investors than RGAGX (0.30). FCAKX is a more actively managed with annual turnover of: 56.00 vs. RGAGX (25.00). FCAKX has a lower initial minimum investment than RGAGX: FCAKX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 7.67 vs. FCAKX (-7.46). RGAGX return over 5 years is better than : 51.11 vs. FCAKX (27.63).
FCAKXRGAGXFCAKX / RGAGX
Total Expense Ratio0.490.30163%
Annual Report Gross Expense Ratio0.490.30163%
Fund Existence17 years16 years-
Gain YTD2.5245.20548%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.55B306B2%
Annual Yield % from dividends0.220.6534%
Returns for 1 year-7.467.67-97%
Returns for 3 years29.8254.6655%
Returns for 5 years27.6351.1154%
Returns for 10 years15.3375.6220%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX124.39-0.62
-0.50%
Neurocrine Biosciences
NMIH40.34-0.26
-0.64%
NMI Holdings
PMCB1.01-0.01
-0.99%
PharmaCyte Biotech
GSBC55.62-1.83
-3.19%
Great Southern Bancorp
CXDO5.14-0.36
-6.55%
Crexendo